Trials / Completed
CompletedNCT00055146
Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
A Multicenter, Phase II Study of ONTAK (Denileukin Diftitox) in Patients With Previously-Treated Chronic Lymphocytic Leukemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (estimated)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of ONTAK in previously treated patients with chronic lymphocytic leukemia (CLL)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONTAK |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2006-03-01
- Completion
- 2006-05-01
- First posted
- 2003-02-21
- Last updated
- 2009-04-17
Locations
14 sites across 5 countries: United States, Argentina, Australia, Brazil, Canada
Source: ClinicalTrials.gov record NCT00055146. Inclusion in this directory is not an endorsement.